Diagnosis

  • Round up: FDA clearance for AI-powered embryo assessment tool

    Femtech World explores the latest developments in the world of technology and women’s health. 30-minute non-invasive test to revolutionise endometriosis detection A new diagnostic tool for endometriosis will now be available in Canada. EndoDiagnosis will be the sole distributor in Canada for the ENDOSURE Tier 1 diagnostic test for the condition, which cuts down the [...]

  • Hydrogel offers hormone-free relief for menopause symptoms

    A hydrogel applied to vaginal tissue could offer hormone-free relief for menopause symptoms, new research suggests. The treatment may help with vaginal dryness and pain linked to genitourinary syndrome of menopause (GSM). GSM occurs when the vaginal and urinary tissues become thinner and drier after menopause. Dr Marianna Alperin, professor and vice chair [...]

  • Letitia James vows to defend NY doctor targeted by Texas over abortion pills

    New York attorney general Letitia James will intervene in Texas’s bid to penalise a New York doctor accused of mailing abortion pills across state lines. The Democratic attorney general announced her intervention on Monday, escalating one of the most consequential fights in the US abortion wars since Roe v Wade was overturned three years ago. [...]

  • Women in UK with PCOS facing widespread failures in treatment, report finds

    Women with polycystic ovarian syndrome face long waits for diagnosis and poor access to treatment, a parliamentary report has warned. More than a third of women with PCOS waited over four years for a diagnosis, according to findings from the all-party parliamentary group. After being diagnosed, 38 per cent said they were not offered any [...]

  • Co-IVF pregnancies may increase risk of serious complications, study suggests

    Women using their partner's egg in co-IVF treatment may face higher risks of complications for themselves and their babies, research suggests. The review of more than 9,000 patients found increased risks of pre-eclampsia and gestational diabetes, alongside lower birth weights, despite higher live birth rates. Co-IVF, or reciprocal IVF, lets women in same-sex relationships share [...]

  • NHS rolls out new generation ‘artificial pancreas’ to help pregnant diabetic women

    Thousands of pregnant women in England with type 1 diabetes will receive a pregnancy-specific artificial pancreas to help manage blood glucose and protect maternal and baby health. The hybrid closed loop system combines an insulin pump, glucose sensor and mobile phone algorithm. It calculates and delivers insulin around the clock, and uniquely allows women to [...]

  • Researchers call for targeted menopause support for autistic women

    Autistic women face serious gaps in menopause support and healthcare, with many reporting poor treatment and a lack of tailored information, a new review shows. The analysis found many were unaware of symptoms when they began, struggled to access appropriate care and often had negative experiences with health services. Three main issues emerged: poor knowledge [...]

  • Better nutrition screening may improve ovarian cancer outcomes, study finds

    Better detection and management of malnutrition and muscle loss could improve treatment results for women with ovarian cancer, new research has found. The study involved a 24-item survey of 57 healthcare professionals across Australia, looking at awareness of nutrition issues, screening practices and barriers to support at diagnosis, during treatment and after treatment. Weight loss, [...]

  • Australia’s biggest fertility company ‘covered up’ IVF mix-up

    A biracial baby was born to a white couple after an IVF error that Australia’s largest fertility provider kept hidden for 11 years, an investigation has found. The baby’s delivery at a Brisbane hospital in 2014 was the first time the couple realised something had gone wrong with their treatment. The case took place at [...]

  • FDA fast-tracks ovarian cancer drug

    The US Food and Drug Administration (FDA) has granted fast track status to stenoparib, an ovarian cancer drug for patients who cannot tolerate platinum-based treatments. The designation, given to medicines addressing serious medical needs, allows more frequent FDA communication and may enable accelerated approval if criteria are met. Allarity Therapeutics is developing stenoparib as an [...]